INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Consensus Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
28.34 ^USD	-0.25%		-1.19%	-34.93%

04-04	North American Morning Briefing : Focus Turns to -2-	DJ
04-03	Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target	MT

Evolution of the average Target Price on Integra LifeSciences Holdings Corporation

Price target over the last 5 years

History of analyst recommendation changes

9fd3202eefbc8.zAMT62UVZ2dtIXGHWAHGKh9y0vDpxOQUVjQ_PersgmE.okh6hAlTNwZaexywNTeqWGsmvpzfr7xfOAwPdrKosS6fYlemKHYSLA9tRQ~5d59aa7e636181973dbded258eea7790

Analyst Recommendations on Integra LifeSciences Holdings Corporation

Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target	04-03	MT
Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target is $38	04-03	MT
Truist Securities Cuts Price Target on Integra LifeSciences Holdings to $41 From $46, Maintains Hold Rating	03-01	MT
Truist Securities Adjusts Price Target on Integra LifeSciences to $46 From $44, Maintains Hold Rating	12-22	MT
Truist Adjusts Integra LifeSciences Holdings' Price Target to $44 From $39, Keeps Hold Rating	12-14	MT
Wells Fargo Upgrades Integra LifeSciences to Overweight From Equalweight, Raises Price Target to $49 From $40	12-05	MT
CL King Starts Coverage on Integra LifeSciences With Buy Rating, $50 Price Target	11-14	MT
Morgan Stanley Adjusts Price Target on Integra LifeSciences to $37 From $44, Maintains Underweight Rating	26/10/23	MT
Morgan Stanley Downgrades Integra LifeSciences to Underweight From Equalweight, Price Target is $44	24/08/23	MT
JMP Securities Adjusts Integra LifeSciences Price Target to $60 From $65, Maintains Market Outperform Rating	28/07/23	MT
Truist Securities Adjusts Price Target on Integra LifeSciences to $48 From $44, Maintains Hold Rating	19/07/23	MT
Is it game over for inflation?	12/07/23
Jefferies Upgrades Integra LifeSciences to Buy From Hold, Cuts Price Target to $53 From $58	12/07/23	MT
ANALYST RECOMMENDATIONS : Activision Blizzard, AstraZeneca, Citigroup, Microsoft, Model N...	12/07/23
Argus Downgrades Integra LifeSciences Holdings to Hold From Buy	08/06/23	MT
Morgan Stanley Adjusts Price Target on Integra LifeSciences to $43 From $59, Keeps Equalweight Rating	31/05/23	MT
JPMorgan Downgrades Integra LifeSciences to Underweight From Neutral, Adjusts Price Target to $43 From $56	24/05/23	MT
ANALYST RECOMMENDATIONS : AMD, Autodesk, Broadcom, National Grid, Sherwin-Williams...	24/05/23
Citigroup Downgrades Integra LifeSciences Holdings to Sell From Neutral, Adjusts Price Target to $39 From $59	23/05/23	MT
Truist Securities Adjusts Price Target on Integra LifeSciences to $54 From $58, Maintains Hold Rating	18/05/23	MT
JMP Securities Adjusts Integra LifeSciences Holdings' Price Target to $65 From $75, Keeps Outperform Rating	27/04/23	MT
Truist Securities Adjusts Price Target on Integra LifeSciences Holdings to $62 From $58, Maintains Hold Rating	17/04/23	MT
Citigroup Adjusts Price Target on Integra LifeSciences Holdings to $59 From $60, Keeps Neutral Rating	23/02/23	MT
Morgan Stanley Raises Price Target on Integra LifeSciences to $59 From $50, Reiterates Equalweight Rating	06/01/23	MT
Truist Securities Adjusts Price Target on Integra LifeSciences Holdings to $58 From $52, Maintains Hold Rating	20/12/22	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

28.34 USD

Average target price

44.8 USD

Spread / Average Target

+58.08%

High Price Target

57 USD

Spread / Highest target

+101.13%

Low Price Target

37 USD

Spread / Lowest Target

+30.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Integra LifeSciences Holdings Corporation

Citigroup
Truist Securities
Wells Fargo Securities
CL King
Morgan Stanley
JMP Securities
Jefferies & Co.
Argus
JPMorgan Chase
Piper Sandler
Oppenheimer
UBS
BofA Securities
Credit Suisse
BTIG

Ratings for Integra LifeSciences Holdings Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar